Private company

JW Pharmaceutical

JW Pharmaceutical is a South Korean company, founded in 1945.¹

JW중외제약(영어: JW Pharmaceutical Corporation)은 1945년 8월 8일에 설립을 한 대한민국의 제약회사이다.² From the Korean Wikipedia, CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

1945Founded¹

Websitewww.jw-pharma.co.kr/pharma/en/main.jsp

See how the biggest companies compare on our leaderboards

Timeline

1945Founded Founded¹

Calendar

Drug trials and FDA: coming up

Mar 31, 2027Phase 4 trial readout expected Phase 4 trial of Empagliflozin/Metformin, Anagliptin and others in Type 2 Diabetes Mellitus (T2DM): primary completion expected Mar 31, 2027 (ClinicalTrials.gov NCT07442006).³

Drug trials and FDA: recently

Jan 22, 2026Phase 4 trial completed Phase 4 trial of Pitavastatin 4mg and Ezetimibe 10 mg in Hypercholesterolemia: primary completion Jan 22, 2026, no results posted yet (ClinicalTrials.gov NCT07442630).⁴

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataJW Pharmaceutical on Wikidata
2
WikipediaJW Pharmaceutical on the Korean Wikipedia
3
ClinicalTrials.govClinicalTrials.gov NCT07442006: Glycemic Variability of Combination Therapies in T2DM
4
ClinicalTrials.govClinicalTrials.gov NCT07442630: Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides